Medical Data Vision Co., Ltd.

TSE:3902.T

513 (JPY) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 1,391.8881,388.5651,931.5791,485.0961,442.881,559.4711,777.0011,470.8611,345.4071,511.331,720.1781,316.9291,205.4251,429.7681,426.2711,106.9041,003.7481,042.8081,269.237971917.172869.1671,173.821931.089769.201703.5011,116.44775.819688.547645.036900.182695.588517.57519.05726.928732.62476.344477.894660.44
Cost of Revenue 376.469342.959402.205328.513336.517320.789296.865281.852243.869251.978295.862248.316216.113268.25230.996155.472157.004153.826154.338179.249169.28159.335174.392288.824179.06155.436173.242197.576129.488119.353145.556114.194104.34793.971133.844180.215109.74692.576133.571
Gross Profit 1,015.4191,045.6061,529.3741,156.5831,106.3631,238.6821,480.1361,189.0091,101.5381,259.3521,424.3161,068.613989.3121,161.5181,195.275951.432846.744888.9821,114.899791.751747.892709.832999.429642.265590.141548.065943.198578.243559.059525.683754.626581.394413.223425.079593.084552.405366.598385.318526.869
Gross Profit Ratio 0.730.7530.7920.7790.7670.7940.8330.8080.8190.8330.8280.8110.8210.8120.8380.860.8440.8520.8780.8150.8150.8170.8510.690.7670.7790.8450.7450.8120.8150.8380.8360.7980.8190.8160.7540.770.8060.798
Reseach & Development Expenses 51.307129.5242.78824.6126.63534.14122.23478.3964.29968.06277.725100.80586.51251.59611300021000000060001600000000
General & Administrative Expenses 000000000000000000000607.368000579.5650000000000000
Selling & Marketing Expenses 000000000000000000000000000000000000000
SG&A 990.657862.427866.939740.27803.817780.88768.053728.204721.502721.066789.976650.205637.481655.24832644601659772600580607.368629621599579.5655465514794614484500000000
Other Expenses -0.030.589-0.1210.0390.2060.489890.287806.594785.972789.128-0.242-0.5680.037-1.3250.150.1552.027-0.647-0.0680.0430.033-0.006-0.0640.0110.0090.042-0.070.318-0.0250.015-13.0920.162-0.495-0.6690.0460.095-0.001-0.009-9.905
Operating Expenses 1,041.964991.951869.727764.882810.452815.02890.287806.594785.972789.128867.701751.01723.993706.836831.469644.393600.422659.753767.196600.236579.965607.368628.904620.855598.956579.565545.647550.997478.78461.674447.4450.448432.266413.261410.836423.318417.179363.579356.341
Operating Income -26.54553.655659.647391.7295.911423.661589.849382.415315.566470.223556.616317.602265.319454.681363.807307.038246.322229.228347.703191.516167.926102.463370.52421.41-8.816-31.499397.55227.24680.27964.008307.225130.946-19.04211.817182.249129.085-50.57921.738170.528
Operating Income Ratio -0.0190.0390.3420.2640.2050.2720.3320.260.2350.3110.3240.2410.220.3180.2550.2770.2450.220.2740.1970.1830.1180.3160.023-0.011-0.0450.3560.0350.1170.0990.3410.188-0.0370.0230.2510.176-0.1060.0450.258
Total Other Income Expenses Net -28.325-30.822-138.508-43.982-21.741.233-322.7380.1540.223-9.109-0.07-0.407-0.317-1.529-70.45-0.4392.027-0.939-151.5830.1-0.2320.003-36.5420.068-0.106-0.055-1.261-2.317-17.572-0.627-135.405-0.49-0.704-0.512-17.618-0.565-0.669-1.253-10.611
Income Before Tax -54.8722.833521.139347.718274.171424.894267.111382.569315.789461.114556.546317.196265.001453.153293.357306.599248.349228.29196.121191.615167.694102.467333.98421.477-8.921-31.555396.29124.92862.70863.381171.82130.456-19.74611.305164.63128.522-51.24920.485159.917
Income Before Tax Ratio -0.0390.0160.270.2340.190.2720.150.260.2350.3050.3240.2410.220.3170.2060.2770.2470.2190.1550.1970.1830.1180.2850.023-0.012-0.0450.3550.0320.0910.0980.1910.188-0.0380.0220.2260.175-0.1080.0430.242
Income Tax Expense 18.46340.196228.535130.48107.402147.207180.213135.23107.627146.446173.97298.73882.618136.53117.90298.71981.1676.301-50.05153.81168.36140.127121.75679.23929.49423.097117.28734.82123.47917.12169.3644.782-4.4315.91557.53547.46-16.1929.57466.311
Net Income -71.089-15.53319.625214.311169.609275.5894.122254.116208.986313.285387.757215.299174.62309.591173.162207.88167.189151.989242.334138.482104.55568.944212.228-55.707-35.135-51.916279.003-9.89239.22846.26102.4685.674-15.3155.39107.09481.061-35.05510.9193.605
Net Income Ratio -0.051-0.0110.1650.1440.1180.1770.0530.1730.1550.2070.2250.1630.1450.2170.1210.1880.1670.1460.1910.1430.1140.0790.181-0.06-0.046-0.0740.25-0.0130.0570.0720.1140.123-0.030.010.1470.111-0.0740.0230.142
EPS -1.86-0.418.375.614.447.212.466.655.478.179.765.464.437.864.395.284.213.826.13.482.611.725.3-0.7-0.44-1.33.49-0.120.490.581.281.07-0.410.142.832.15-0.950.32.54
EPS Diluted -1.86-0.418.375.614.447.212.466.635.458.179.765.464.437.864.395.284.213.826.13.482.611.725.3-0.7-0.44-1.33.49-0.120.490.581.281.07-0.410.142.832.15-0.950.282.54
EBITDA -1.7772.796686.082407.376296.802423.49913.927382.36315.394470.053556.445317.456265.674454.898434.407307.644246.322229.53347.677191.615167.695102.509370.50721.479-8.764-31.34397.13726.97862.4464.008293.463130.463-19.7411.312179.139129.237-50.5822.408154.749
EBITDA Ratio -0.0010.0520.3550.2740.2060.2720.5140.260.2340.3110.3230.2410.220.3180.3050.2780.2450.220.2740.1970.1830.1180.3160.023-0.011-0.0450.3560.0350.0910.0990.3260.188-0.0380.0220.2460.176-0.1060.0470.234